The financing was led by TCGX and included TPG, Orbimed Advisors, Venrock Healthcare Capital Partners, Surveyor Capital, and Logos Capital, as new investors, with all of Adcendo's existing backers ...

Denmark-based Adcendo is the latest biotech to secure funding in the antibody-drug conjugate (ADC) space, raising $135m to advance its portfolio of first-in-class ADCs into the clinic. Founded in ...